参考文献/References:
［1］LIU Z, XU H, KANG X, et al. Allogenic lymphocyte immunotherapy for unexplained recurrent spontaneous abortion: a Metaanalysis ［J］. American Journal of Reproductive Immunology (New York, N.Y.： 1989), 2016, 76 (6): 443-453.
［2］TONG M, VIALL C A, CHAMLEY L W. Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment ［J］. Human Reproduction Update, 2015, 21 (1): 97-118.
［3］LATA K, DUTTA P, SRIDHAR S, et al. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a casecontrol study ［J］. Endocrine Connections, 2013, 2 (2): 118-124.
［4］石瑛，路璐，王云凤，等．反复自然流产与封闭抗体相关性的Meta分析 ［J］．中国实验诊断学，2017，21（7）：1195-1198．
［5］GUO Wen-wei, FANG Liang, LI Bo, et al. Decreased human leukocyte Antigen-G expression by mir-133a contributes to impairment of proinvasion and proangiogenesis functions of decidual NK cells ［J］. Frontiers in Immunology, 2017, 8: 741.
［6］QIAN J, ZHANG N, LIN J, et al. Distinct pattern of Th17/Treg cells in pregnant women with a history of unexplained recurrent spontaneous abortion ［J］. Bioscience Trends, 2018, 12 (2): 157-167.
［7］LU Chang, LIU Yong, JIANG Hai-li. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a Meta-analysis of randomized controlled trials ［J］. Journal of Maternal-Fetal & Neonatal Medicine, 2019, 32 (8): 1299-1311.
［8］中华医学会妇产科学分会产科学组．复发性流产诊治的专家共识 ［J］．中华妇产科杂志，2016，51（1）：3-9．
［9］MAESAWA Y, DEGUCHI M, TANIMURA K, et al. Effectiveness of high-dose iv immunoglobulin therapy for pregnant women with aspirin-heparin-resistant secondary antiphospholipid syndrome ［J］. Reproductive Medicine and Biology, 2018, 17 (2): 149-154.
［10］YE Sheng-long, GU Xun-ke, TAO Li-yuan, et al. Efficacy of different treatment regimens for antiphospholipid syndrome-related recurrent spontaneous abortion ［J］. Chinese Medical Journal, 2017, 130 (12): 1395-1399.
［11］SCHREIBER K, BREEN K, COHEN H, et al. Hydroxychloroquine to improve pregnancy outcome in women with antiphospholipid antibodies(HYPATIA)protocol:a multinational randomized controlled trial of hydroxychloroquine versus placebo in addition to standard treatment in pregnant women with antiphospholipid syndrome or antibodies ［J］. Seminars in Thrombosis and Hemostasis, 2017, 43 (6): 562-571.
［12］FLINT J, PANCHAL S, HURRELL A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice ［J］. Rheumatology (Oxford, England), 2016, 55 (9): 1698-1702.
［13］NEGRO R, FORMOSO G, MANGIERI T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications ［J］. The Journal of Clinical Endocrinology and Metabolism, 2006, 91 (7): 2587-2591.
［14］NAZARPOUR S, TEHRANI F R, SIMBAR M A, et al. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease ［J］. European Journal of Endocrinology, 2017, 176 (2): 253-265.
［15］WONG L F, PORTER T F. Immunotherapy for recurrent miscarriage ［J］. The Cochrane Database of Systematic Reviews, 2014 (10): CD000112.
［16］CAVALCANTE M B, COSTA F D, ARAUJO JúNIOR E, et al. Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy［J］. Journal of Maternal-Fetal & Neonatal Medicine, 2015, 28(9): 1082-1086.
［17］WANG Si-wei, ZHONG Song-yang, LOU Li-jun, et al. The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysis ［J］. Reproductive BioMedicine Online, 2016, 33 (6): 720-736.
［18］YAMADA H, DEGUCHI M, MAESAWA Y, et al. Medium-dose intravenous immunoglobulin therapy for women with six or more recurrent miscarriages ［J］. Journal of Reproductive Immunology, 2015, 109 (6): 48-51.
［19］RAMOS-MEDINA R, GARCIA-SEGOVIA A, GIL J A, et al. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion ［J］. American Journal of Reproductive Immunology, 2014, 71 (5): 458-466.
［20］Ahmadi M, Aghdam SA, Nouri M, et al. Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Nonrandomized,open-label clinical trial ［J］.Immunology letters,2017,192 (12):12-19.
［21］XU Guang-li, HU Xiao-fang, HAN Yong-mei, et al. Clinical efficacy of low molecular heparin on unexplained recurrent spontaneous abortion ［J］. Clinical Laboratory, 2018, 64 (6): 1037-1040.
［22］CETIN O, KARAMAN E, CIM N, et al. The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism ［J］. Ginekologia Polska, 2017, 88 (5): 260-265.
［23］PASQUIER E, DE SAINT MARTIN L, BOHEC C, et al. Enoxaparin for prevention of unexplained recurrent miscarriage:a multicenter randomized double-blind placebo-controlled trial ［J］. Blood, 2015, 125 (14): 2200-2205.
［24］MAGED A M, ABDELHAFIZ A, AL MOSTAFA W A, et al. The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion ［J］. Gynecological Endocrinology, 2016, 32 (12): 970-972.
［25］LU Xuefeng, LIU Zhilan, ZHANG Xiaoxin, et al. Prothrombotic state of patients with unexplained recurrent spontaneous abortion ［J］. International Journal of Gynaecology and Obstetrics, 2015, 131 (2): 161-165.
［26］KOO H S, KWAK-KIM J, YI H J, et al. Resistance of uterine radial artery blood flow was correlated with peripheral blood NK cell fraction and improved with low molecular weight heparin therapy in women with unexplained recurrent pregnancy loss ［J］. American Journal of Reproductive Immunology, 2015, 73 (2): 175-184.
［27］KUMAR A, BEGUM N, PRASAD S, et al. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial ［J］. Fertility and Sterility, 2014, 102 (5): 1357-1363.
［28］ISMAIL A M, ABBAS A M, ALI M K, et al. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial ［J］. Journal of Maternal-Fetal & Neonatal Medicine, 2018, 31 (3): 388-394.
［29］COOMARASAMY A, WILLIAMS H, TRUCHANOWICZ E, et al. A randomized trial of progesterone in women with recurrent miscarriages ［J］. The New England Journal of Medicine, 2015, 373 (22): 2141-2148.
［30］GOMAA M F, ELKHOLY A G, EL-SAID M M. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial ［J］. Archives of Gynecology and Obstetrics, 2014, 290 (4): 757-762.
［31］TANG Ai-wei, ALFIREVIC Z, TURNER M A, et al. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant ［J］. Human Reproduction, 2013, 28 (7): 1743-1752.
［32］SCARPELLINI F, SBRACIA M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial ［J］. Human Reproduction (Oxford, England), 2009, 24 (11): 2703-2708.
［33］ZAFARDOUST S, AKHONDI M M, SADEGHI M R, et al. Efficacy of intrauterine injection of granulocyte colony stimulating factor(G-CSF)on treatment of unexplained recurrent miscarriage:a pilot RCT study ［J］. Journal of Reproduction & Infertility, 2017, 18 (4): 379-385.
［34］付锦华，朱霄鹤，孙红，等．环孢素A治疗难治性免疫性复发性流产随机对照研究 ［J］．中国实用妇科与产科杂志，2016,32（5）：441-445．
［35］LING Yi, HUANG Yuan-hua, CHEN Cai-xia, et al. Low dose Cyclosporin：A treatment increases live birth rate of unexplained recurrent abortion-initial cohort study ［J］. Clinical and Experimental Obstetrics & Gynecology, 2017, 44 (2): 230-235.
［36］DAKHLY D M, BAYOUMI Y A, SHARKAWY M A, et al. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells ［J］. International Journal of Gynecology & Obstetrics, 2016, 135 (3): 324-327.
［37］CHEN Xiao-jing, YANG Xiao-qing, WU Rong-rong, et al. Therapeutic effects of Wharton jelly-derived mesenchymal stem cells on rat abortion models ［J］. Journal of Obstetrics and Gynaecology Research, 2016, 42 (8): 972-982.
［38］吴荣荣，张玉泉，徐云钊，等．人脐带间充质干细胞移植治疗小鼠复发性自然流产效果及其机制探讨 ［J］．山东医药，2017，57（3）：9-12．
［39］MENG Yu-han, ZHU Xiao-hui, YAN Li-ying, et al. Bone mesenchymal stem cells improve pregnancy outcome by inducing maternal tolerance to the allogeneic fetus in abortion-prone matings in mouse ［J］. Placenta, 2016, 47 (11): 29-36.
［40］FARROKHI A S, ZARNANI A H, MOAZZENI S M. Mesenchymal stem cells therapy protects fetuses from resorption and induces Th2 type cytokines profile in abortion prone mouse model ［J］. Transplant Immunology, 2018, 47 (4): 26-31.
相似文献/References:
[1]雷贞武.各种先天性子宫异常与复发性流产的临床问题[J].中国计划生育和妇产科,2009,(06):0.
[2]万波,颜友良,胡文娟,等.心理干预与复发性流产妊娠结局的研讨[J].中国计划生育和妇产科,2013,(01):0.
WAN Bo,YAN You-liang*,HU Wen-juan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(1):0.
[3]李树侠,张弘,陈昕,等.宫腔镜检查在复发性流产患者诊治中的作用[J].中国计划生育和妇产科,2013,(05):0.
LI Shu-xia,ZHANG Hong,CHEN Xin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(1):0.
[4]庞小艳,邓小清,肖翠艳,等.复发性流产患者清宫术中个性化护理的临床观察[J].中国计划生育和妇产科,2014,(08):0.
PANG Xiao-yan,DENG Xiao-qing,XIAO Cui-yan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(1):0.
[5]廖红玉.阿司匹林联合地塞米松孕前干预D2聚体升高型复发性流产的疗效分析[J].中国计划生育和妇产科,2015,(07):0.
LIAO Hong-yu,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(1):0.
[6]康丹阳,杨巧妮,乔宠*.应用血栓弹力图监测不同流产次数的复发性流产患者凝血功能变化情况[J].中国计划生育和妇产科,2017,(2):22.
KANG Dan-yang,YANG Qiao-ni,QIAO Chong*.Application of thrombelastography to monitor the change of coagulation function in patients of recurrent spontaneous abortion in different times[J].Chinese Journal of Family Planning & Gynecotokology,2017,(1):22.
[7]刘素华*,赵阳阳,訾苹苹,等.肝素对复发性流产患者凝血功能、并发症及妊娠结局的影响[J].中国计划生育和妇产科,2017,(5):44.
LIU Su-hua*,ZHAO Yang-yang,ZI Ping-ping,et al.Effect of heparin on coagulation function, complication and pregnancy outcome in patients with recurrent spontaneous abortion[J].Chinese Journal of Family Planning & Gynecotokology,2017,(1):44.
[8]杨纨,王海燕*.多囊卵巢综合征与复发性流产[J].中国计划生育和妇产科,2017,(10):1.
[9]罗云瑶,程冉,许良智*.复发性流产与染色体相关因素的研究进展[J].中国计划生育和妇产科,2017,(10):7.
[10]欧玉华,张建平*.低分子肝素在复发性流产中应用的现状研究[J].中国计划生育和妇产科,2017,(10):10.